Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Axonics Inc
(NQ:
AXNX
)
69.17
+0.07 (+0.09%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Axonics Inc
< Previous
1
2
3
Next >
Axonics to Report Fourth Quarter 2022 Financial Results on March 1
February 08, 2023
From
Axonics, Inc.
Via
Business Wire
Axonics Receives FDA Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System
January 31, 2023
From
Axonics, Inc.
Via
Business Wire
Axonics Reports Preliminary Fiscal Year 2022 Revenue and Provides Fiscal Year 2023 Revenue Guidance
January 11, 2023
From
Axonics, Inc.
Via
Business Wire
Axonics to Present at the 41st Annual J.P. Morgan Healthcare Conference
December 21, 2022
From
Axonics, Inc.
Via
Business Wire
Axonics Receives Health Canada Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System
December 13, 2022
From
Axonics, Inc.
Via
Business Wire
Axonics® to Participate in the Piper Sandler Healthcare Conference
November 18, 2022
From
Axonics, Inc.
Via
Business Wire
Axonics® Ranked No. 4 on the 2022 Deloitte Technology Fast 500™ List of the Fastest Growing Companies in North America
November 16, 2022
From
Axonics, Inc.
Via
Business Wire
Axonics® Reports Third Quarter 2022 Financial Results
October 31, 2022
From
Axonics, Inc.
Via
Business Wire
Is This Medical Gear Maker Ready To Continue Its Rally?
September 15, 2022
Medical gear maker Axonics rallied to a new high after an announcement that it entered the Canadian market. Is it set for bigger gains on strong revenue growth?
Via
MarketBeat
Topics
Intellectual Property
Exposures
Intellectual Property
Axonics® Announces First Patient Implants in Canada With New Recharge-Free Sacral Neuromodulation System
September 08, 2022
From
Axonics, Inc.
Via
Business Wire
Axonics® to Participate in September Investor Conferences
August 18, 2022
From
Axonics, Inc.
Via
Business Wire
Axonics® Expands Sacral Neuromodulation Intellectual Property Portfolio
August 17, 2022
From
Axonics, Inc.
Via
Business Wire
Axonics® Announces Closing of Public Stock Offering and Full Exercise of Underwriter’s Option to Purchase Additional Stock
August 05, 2022
From
Axonics, Inc.
Via
Business Wire
Axonics® Announces Pricing of Public Offering of Common Stock
August 02, 2022
From
Axonics, Inc.
Via
Business Wire
Axonics® Announces Proposed Public Offering of Common Stock
August 02, 2022
From
Axonics, Inc.
Via
Business Wire
Axonics® Reports Second Quarter 2022 Financial Results
August 01, 2022
From
Axonics, Inc.
Via
Business Wire
Axonics® to Report Second Quarter 2022 Financial Results on August 1
July 11, 2022
From
Axonics, Inc.
Via
Business Wire
Axonics® Files PMA Supplement with FDA for Fourth Generation Rechargeable Neurostimulator
May 31, 2022
From
Axonics, Inc.
Via
Business Wire
Axonics® Reports First Quarter 2022 Financial Results
May 05, 2022
From
Axonics, Inc.
Via
Business Wire
Axonics® to Participate in BofA Securities 2022 Healthcare Conference
April 26, 2022
From
Axonics, Inc.
Via
Business Wire
Axonics® Announces Comprehensive Launch of the Axonics F15™ Recharge-Free Sacral Neuromodulation System
April 19, 2022
From
Axonics, Inc.
Via
Business Wire
Axonics® to Report First Quarter 2022 Financial Results on May 5
April 14, 2022
From
Axonics, Inc.
Via
Business Wire
Axonics® Launches Direct to Consumer Television Advertising Campaign
April 04, 2022
From
Axonics, Inc.
Via
Business Wire
Axonics® Reports Fourth Quarter and Fiscal Year 2021 Financial Results
February 24, 2022
From
Axonics, Inc.
Via
Business Wire
Axonics® to Report Fourth Quarter and Fiscal Year 2021 Financial Results on February 24
February 03, 2022
From
Axonics, Inc.
Via
Business Wire
Axonics® to Participate in SVB Leerink Virtual Healthcare Conference
February 01, 2022
From
Axonics, Inc.
Via
Business Wire
New Study Finds More Than 60% of Adult Women in the U.S. Experience Urinary Incontinence
January 25, 2022
From
Axonics, Inc.
Via
Business Wire
Axonics® Reports Preliminary Fourth Quarter and Fiscal Year 2021 Revenue
January 06, 2022
From
Axonics, Inc.
Via
Business Wire
Axonics® CEO Raymond W. Cohen Receives Lifetime Entrepreneurial Achievement Award by the Southern California Biomedical Council
November 30, 2021
From
Axonics, Inc.
Via
Business Wire
Axonics® Ranked the Fastest-Growing Company in North America on the 2021 Deloitte Technology Fast 500™
November 17, 2021
From
Axonics, Inc.
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.